Description: Nearly 25% of all women and 10% of men suffer from urinary incontinence, a condition whose incidence and severity increases with age. Most absorbent devices (incontinence pads) are merely diapers for adults. The use of these pads is most effective when utilized as part of a treatment plan and once a diagnosis is made. An ideal device would be one which allows the user to determine the nature and amount of fluid leaked and to visually determine via color change technology whether or not less leakage is occurring over time and treatment. The confidence-building incontinence pad is thus such a device. Whether treatment plan involves biofeedback, physical therapy, medication, vaginal support device (pessary), surgery or combination therapy, the confidence building incontinence pad will offer immediate feedback as to whether or not improvement is occurring. Three discrete zones are delineated within the pad, each containing a different qualitative and quantitative chemical reaction utilizing different volume-based reagents. When exposed to a small amount of urine, the first or core zone (located over the urethral meatus/most central) undergoes a color change reaction (light yellow-green-turquoise) utilizing an enzymatic moisture indicator. This zone would change color with the smallest volume of urine up to and including 10-20 cc’s. The middle zone volume capacity is from 20-100cc’s and the outer zone’s capacity is greater than 100 cc’s. Both the middle and outer zones are associated with discrete color change reactions. The three zones’ reactions are visually distinct and the device includes fluid wicking in order to enhance an individual’s comfort. Thus, an individual may determine not only the relative amount of urinary leakage and the extent of their incontinence, but their progress towards improvement during their treatment plan. The individual becomes a partner in their treatment, benefits from feedback and reward of clinical improvement and thus confidence builds with time.
Area of Application: An absorbent device which allows for determination of amount of urinary leakage and which permits feedback information to determine severity of condition as well as improvement over time.
Lead Investigator: Jill Rabin, MD
Patent Info: US Patent No. 6,284,942, Issued September 4, 2001
350 Community Drive
Manhasset, New York 11030
Phone: (516) 562-3404
Fax: (516) 562-2356